We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Indian Drugmaker for Discarded Records, Scant Investigations
FDA Warns Indian Drugmaker for Discarded Records, Scant Investigations
The FDA hit Strides Pharma Science with a warning letter for discarding records and other serious violations at the generic drugmaker’s facility in Puducherry, India.